{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"588.116822","value":"1863.9375"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Serum concentration of alisertib on the first day of administration three hours after administration in nanograms/milliliter.","dispersionType":"Standard Deviation","groups":[{"description":"All patients.","id":"OG000","title":"All Patients"}],"paramType":"MEAN","populationDescription":"Of all eligible patients enrolled, 16 provided a first day of administration three hours after administration sample for analysis.","reportingStatus":"POSTED","timeFrame":"day 1 of protocol therapy","title":"Serum Concentration of Alisertib on the First Day of Administration Three Hours After Administration","type":"SECONDARY","unitOfMeasure":"ng/ml"}